| Dr Heather Helena Kiraly Orkwis, DO | |
|
43900 Garfield Rd Ste 100, Clinton Township, MI 48038-1137 | |
| (586) 286-0112 | |
| (586) 286-1241 |
| Full Name | Dr Heather Helena Kiraly Orkwis |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 15 Years |
| Location | 43900 Garfield Rd Ste 100, Clinton Township, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750514865 | NPI | - | NPPES |
| 5101018912 | Other | MI | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OS016473 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Center For Dermatology And Pathology Pllc | 0446330492 | 43 |
News Archive
Altered cognitive processes and attitudes in patients with bipolar disorder are mostly associated with symptomatology, say researchers.
Alcohol-use disorders (AUDs) can damage the brain, particularly the frontal and parietal cortices, although this damage is at least partially reversible with sustained abstinence from alcohol. Chronic smoking is extremely common among individuals with AUDs.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).
According to researchers at Australian bioscience company Living Cell Technologies (LCT), if approved, pig brain cells wrapped in a seaweed derivative could be implanted into human brains by sometime next year to treat Huntington's disease.
› Verified 3 days ago
| Entity Name | Midwest Center For Dermatology & Pathology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003095084 PECOS PAC ID: 0446330492 Enrollment ID: O20080103000679 |
News Archive
Altered cognitive processes and attitudes in patients with bipolar disorder are mostly associated with symptomatology, say researchers.
Alcohol-use disorders (AUDs) can damage the brain, particularly the frontal and parietal cortices, although this damage is at least partially reversible with sustained abstinence from alcohol. Chronic smoking is extremely common among individuals with AUDs.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).
According to researchers at Australian bioscience company Living Cell Technologies (LCT), if approved, pig brain cells wrapped in a seaweed derivative could be implanted into human brains by sometime next year to treat Huntington's disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heather Helena Kiraly Orkwis, DO 43900 Garfield Rd, Suite 100, Clinton Township, MI 48038-1137 Ph: (586) 286-0112 | Dr Heather Helena Kiraly Orkwis, DO 43900 Garfield Rd Ste 100, Clinton Township, MI 48038-1137 Ph: (586) 286-0112 |
News Archive
Altered cognitive processes and attitudes in patients with bipolar disorder are mostly associated with symptomatology, say researchers.
Alcohol-use disorders (AUDs) can damage the brain, particularly the frontal and parietal cortices, although this damage is at least partially reversible with sustained abstinence from alcohol. Chronic smoking is extremely common among individuals with AUDs.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).
According to researchers at Australian bioscience company Living Cell Technologies (LCT), if approved, pig brain cells wrapped in a seaweed derivative could be implanted into human brains by sometime next year to treat Huntington's disease.
› Verified 3 days ago
Jennifer L Rivard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 43151 Dalcoma Dr, Suite 3, Clinton Township, MI 48038 Phone: 586-286-8720 Fax: 866-790-6803 | |
Mary Georgia Veremis-ley, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 43900 Garfield Rd, Ste 100, Clinton Township, MI 48038 Phone: 586-286-2544 Fax: 586-286-0534 | |
Tiffany Cukrowski, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 43900 Garfield Rd, Ste 100, Clinton Township, MI 48038 Phone: 586-286-2544 Fax: 586-286-0534 | |
Dr. Cynthia Tseng Chow, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 43151 Dalcoma Dr Ste 1, Clinton Township, MI 48038 Phone: 586-286-8720 Fax: 586-286-8723 | |
Dr. Lenise Anne Banse, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 42452 Hayes Rd, Suite 3, Clinton Township, MI 48038 Phone: 586-263-3130 Fax: 586-263-5183 | |
Dr. Kent Jerome Krach, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 43900 Garfield Road, Suite 100, Clinton Township, MI 48038 Phone: 586-286-0112 Fax: 586-286-2702 | |
Dr. Fiorino M Digregorio, MD Dermatology Medicare: Medicare Enrolled Practice Location: 16510 19 Mile Rd, Clinton Township, MI 48038 Phone: 586-263-7200 Fax: 586-286-8007 |